BOARD OF DIRECTORS
The N2 Board of Directors consists of 10 individuals representing from across Canada.
Jim Pankovich
Chair
Executive Vice President, Clinical Development, Bold Therapeutics Inc
Rachel Syme
Vice Chair
N2 Board Member
N2 Vice Chair
Program Director, Research, Cystic Fibrosis Canada
Patrick Clifford
Treasurer
N2 Board Member
N2 Treasurer
Erin Cherban
Secretary
Chief Research Officer Centre for Health Evaluation & Outcome Sciences (CHÉOS), CIHR Canadian HIV Trials Network (CTN)
Daniela M. Bianco
Board Member
Manager, Research Development & Relations, Hamilton Health Sciences
Kathy Brodeur-Robb
Board Member
Executive Director C-17 Council
Jennifer Li
Board Member
Quality Manager, Cancer Clinical Research Unit, Princess Margaret Cancer Centre – University Health Network
Tammy Mah-Fraser
Board Member
Executive Director, Health Platforms, Alberta Innovates
Janette Panhuis
Board Member
N2 Board Member
Jordan Warford
Senior Director of Research for Nova Scotia Health
N2 Board Member